Surface a possible catalyst without mistaking sentiment or a headline for a validated clinical or trading signal.

Illustrative idea, not a published runnable template. Grunt is prelaunch; live service is paused and live provider connections and outcomes remain unverified. The steps, providers, and outcomes below describe a concept.

For a team with an authorized purpose, prepare a source-linked research brief about selected biotech news for a qualified analyst to verify. Clinical and regulatory reports can change quickly, and misreading a trial result can affect health and financial decisions. Check primary company and regulator sources, preserve dates and study context, avoid medical or investment advice, protect positions and client information, and require qualified review before any trade or public claim. Explain personal-data use and retention, obtain required consent, respect source and reuse rights, verify important details, and keep external or consequential actions under human approval.

Actual availability depends on published steps, supported connections, permissions, and provider approval.